Researchers developed highly optimized small molecule-inducible synthetic erythropoietin (EPO) receptors (synEPORs) using design-build-test cycles and genome editing. They integrated synEPOR at the endogenous EPOR locus in O-negative induced pluripotent stem cells.
[Nature Communications]